Outcome

This study on children aged 8 to 15 with persistent post-concussion syndrome (PPCS) following a traumatic brain injury (TBI) found that 60 daily sessions of hyperbaric oxygen therapy (HBOT) significantly improved cognitive and behavioral functions PPCS symptoms and quality of life. Improvements were noted in general cognitive score memory executive function emotional symptoms hyperactivity and planning/organizing scores.

Introduction

Persistent post-concussion syndrome (PPCS) in children can profoundly impact their cognitive and behavioral development. This study conducted on children aged 8 to 15 who have suffered from mild to moderate traumatic brain injury (TBI) up to ten years prior explores the potential benefits of hyperbaric oxygen therapy (HBOT). Through 60 daily sessions the children receiving HBOT showed remarkable improvements in cognitive functions such as memory executive function and overall cognitive scores. Additionally significant enhancements were observed in behavioral symptoms emotional well-being and quality of life. Brain MRI scans revealed notable microstructural changes in several key regions of the brain. This research underscores the potential of HBOT as an effective treatment for PPCS in pediatric patients highlighting its capacity to promote recovery even many years after the initial injury. The findings suggest a promising avenue for improving the lives of children struggling with long-term effects of concussions.

Results

The study conducted on children aged 8 to 15 with persistent post-concussion syndrome (PPCS) following mild to moderate traumatic brain injury (TBI) showed promising results with hyperbaric oxygen therapy (HBOT). These children who had been suffering from PPCS for up to 10 years were given 60 daily sessions of HBOT or a placebo treatment. The study revealed significant improvements in several areas among those who received HBOT.

Key cognitive functions including general cognitive score memory and executive function saw marked improvements. Specifically the general cognitive score increased with a significant effect memory improved noticeably and executive function showed robust gains. Emotionally there were notable improvements in PPCS symptoms including the emotional score and behavioral symptoms such as hyperactivity.

Additionally the global executive composite score and planning/organizing skills also saw significant enhancements. These clinical outcomes were supported by improvements in brain MRI microstructural changes in various regions including the insula supramarginal lingual inferior frontal and fusiform gyrus.

Overall the study concluded that HBOT significantly improves cognitive and behavioral functions reduces PPCS symptoms and enhances the quality of life in pediatric patients who are at a chronic stage of PPCS even many years post-injury. These findings suggest that HBOT can be an effective treatment for children with PPCS and underscores the need for further research to optimize the treatment protocols and better identify which children will benefit the most from this therapy.

Conclusion

In conclusion this study provides compelling evidence that HBOT significantly improves cognitive function behavioral function and quality of life in children with persistent post-concussion syndrome (PPCS) even years after a mild to moderate traumatic brain injury. The randomized sham-controlled double-blind trial demonstrated notable enhancements in various cognitive metrics such as general cognitive scores memory and executive function. Additionally improvements were observed in behavioral measures including reductions in hyperactivity and better emotional regulation. These clinical outcomes were supported by brain MRI findings showing significant microstructural changes in several brain regions associated with cognitive and behavioral function. Overall this study suggests that HBOT is a promising treatment for pediatric patients suffering from long-term PPCS.